- Home
- IMMP vs UROY Comparison
IMMP vs UROY Comparison
Compare IMMP & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- UROY
- Stock Information
- Founded
- IMMP 1987
- UROY 2017
- Country
- IMMP Australia
- UROY Canada
- Employees
- IMMP N/A
- UROY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- UROY
- Sector
- IMMP Health Care
- UROY
- Exchange
- IMMP Nasdaq
- UROY Nasdaq
- Market Cap
- IMMP 211.1M
- UROY 312.7M
- IPO Year
- IMMP N/A
- UROY N/A
- Fundamental
- Price
- IMMP $1.78
- UROY $2.28
- Analyst Decision
- IMMP Buy
- UROY Strong Buy
- Analyst Count
- IMMP 1
- UROY 2
- Target Price
- IMMP $7.00
- UROY $4.00
- AVG Volume (30 Days)
- IMMP 150.7K
- UROY 3.8M
- Earning Date
- IMMP 02-27-2025
- UROY 07-23-2025
- Dividend Yield
- IMMP N/A
- UROY N/A
- EPS Growth
- IMMP N/A
- UROY N/A
- EPS
- IMMP N/A
- UROY N/A
- Revenue
- IMMP $3,019,249.00
- UROY $15,984,827.00
- Revenue This Year
- IMMP $50.37
- UROY N/A
- Revenue Next Year
- IMMP N/A
- UROY N/A
- P/E Ratio
- IMMP N/A
- UROY N/A
- Revenue Growth
- IMMP 24.11
- UROY N/A
- 52 Week Low
- IMMP $1.32
- UROY $1.43
- 52 Week High
- IMMP $2.86
- UROY $3.12
- Technical
- Relative Strength Index (RSI)
- IMMP 44.44
- UROY 63.49
- Support Level
- IMMP $1.88
- UROY $2.13
- Resistance Level
- IMMP $1.94
- UROY $2.45
- Average True Range (ATR)
- IMMP 0.12
- UROY 0.13
- MACD
- IMMP -0.03
- UROY 0.01
- Stochastic Oscillator
- IMMP 0.00
- UROY 73.64
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.